Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Dyktig sykepleie i hjemmet

3. november 2026 oppdatert av: David Levine, Brigham and Women's Hospital

Dyktig sykepleie i hjemmet: En randomisert kontrollert prøvelse

We will perform a parallel-group multicenter patient-level randomized controlled evaluation of skilled nursing facility care at home. Patients typically referred to a skilled nursing facility following hospitalization will be eligible for enrollment. Instead of admission to a skilled nursing facility, participants will receive care from a technology-enabled team in their own homes or will be allocated to receive care in a traditional skilled nursing facility setting.

Studieoversikt

Studietype

Intervensjonell

Registrering (Faktiske)

244

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Massachusetts
      • Boston, Massachusetts, Forente stater, 02114
        • Massachusetts General Hospital
      • Boston, Massachusetts, Forente stater, 02118
        • Boston Medical Center
      • Boston, Massachusetts, Forente stater, 02120
        • Brigham and Women's Hospital
      • Boston, Massachusetts, Forente stater, 02130
        • Brigham and Women's Faulkner Hospital
      • Cambridge, Massachusetts, Forente stater, 02139
        • Cambridge Health Alliance

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • >=18 years old
  • Requires SNF PAC care following hospitalization, as determined by the inpatient team (requires documented rehabilitative therapy recommendation)
  • Community-dwelling before hospitalization
  • Likely to return to community-dwelling status following short-term rehabilitation as determined by RAH liaison
  • Lives within 10 miles of any study site hospital (or per specified catchment)
  • Surgical trauma and elective patients (weight bearing as tolerated and transfer with no more than one-person assist)
  • Neurology patients - Stroke (needs acute rehabilitation, but insurance will not cover, so bound for SNF. Does not meet acute rehabilitation criteria and does not need long-term placement)

Exclusion Criteria:

  • Environmental

    • Undomiciled
    • No working heat (October-April), no working air conditioning if forecast > 80°F, or no running water
    • In police custody
    • Resides in a facility that does not allow advanced on-site care
    • Domestic violence screen positive
    • Weapons that cannot be appropriately secured
    • Difficulty accessing the bathroom (unless there is space for a bedside commode where the patient sleeps or if the patient is entirely dependent on toileting)
    • Home has insufficient accessible space to sleep, eat, and perform rehabilitative therapy
    • Home lacks sufficient kitchen facilities to either cook or heat meals
    • Patient, or patient's family caregiver, unable to communicate via telephone
    • Patient, or patient's family caregiver, lacks consistent access to a telephone
  • Clinical

    • Requires more than one assist (unless the family can provide additional 24/7 assistance)
    • Requires care of new ostomy or teaching ostomy care
    • Requires frequent suctioning, tracheostomy, and ventilator needs
    • Requires total parenteral nutrition
    • Requires nasogastric tube feeds
    • Requires durable medical equipment not already in place at home and excluded below
    • Requires daily subcutaneous injection unless patient or family caregiver is teachable and able to administer daily
    • Acute delirium noted by RAH liaison requiring more than one caregiver
    • Active psychiatric diagnosis without an adequate treatment plan
    • On methadone requiring daily pickup of medication
    • Requires administration of intravenous controlled substances
    • Requires administration of specialty medications not already in place at home
    • Requires transfusion of blood products
    • Requires three times weekly or more transfers back and forth to obtain specialty medical care
    • Requires hemodialysis
    • Orthopedic trauma and elective patients
    • Traumatic brain injury
    • Wound or appliance care that requires daily nursing care
    • For spine trauma: neurologic deficits requiring more than one assist
  • Neurology patients

    • PRESS score (for ischemic stroke; use PRESS app): no return to pre-stroke diet > 50%
    • FUNC score (for primary intracerebral hemorrhage only): <75% probability of functional independence at 90 days
    • ASTRAL score (for ischemic stroke only and patients with pre-stroke independence [Modified Rankin Scale 0-2]): <75% probability of a 90-day poor functional outcome (Modified Rankin Scale result of 3-6)
  • RAH census is full

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Annen
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Dobbelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Ingen inngripen: Usual skilled nursing facility care

Control subjects will receive care at a skilled nursing facility as per usual.

Aktiv komparator: Rehab at home

Intervention subjects will receive care in their home from a specialized care team.

Skilled nursing facility care at home delivers a range of advanced rehabilitation services in patients' homes, enabling care at home despite requiring intensive rehabilitative care. Our approach blends personalized, high-level professional care with innovative technology applications to ensure adequate rehabilitation.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in activities of daily living between admission to rehab and discharge from rehab
Tidsramme: Admission to rehab until discharge from rehab, no more than 6 months

Subtract the patient's activities of daily living at discharge from rehab from the patient's activities of daily living on admission to rehab.

Admission to rehab until discharge from rehab, no more than 6 months

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Percent time supine per day
Tidsramme: Admission to rehab until discharge from rehab, no more than 6 months

The percentage of time a patient is supine per day, as measured by their wrist-worn accelerometer.

Admission to rehab until discharge from rehab, no more than 6 months
Total direct medical expenditure
Tidsramme: Admission to rehab until discharge from rehab, no more than 6 months

The percent difference in direct cost of care to deliver rehab care.

Admission to rehab until discharge from rehab, no more than 6 months
Patient experience with care
Tidsramme: Admission to rehab until discharge from rehab, no more than 6 months

The Picker patient experience questionaire-15

Admission to rehab until discharge from rehab, no more than 6 months
30-day readmission or 30-day mortality
Tidsramme: Discharge from rehab until 30-days later, no more than 30-days

The percentage of patients who are readmitted or deceased within 30-days of discharge from rehab.

Discharge from rehab until 30-days later, no more than 30-days

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

3. juni 2024

Primær fullføring (Faktiske)

22. oktober 2025

Studiet fullført (Faktiske)

2. april 2026

Datoer for studieregistrering

Først innsendt

11. mai 2024

Først innsendt som oppfylte QC-kriteriene

11. mai 2024

Først lagt ut (Faktiske)

16. mai 2024

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

5. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

3. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • 2024P000266

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere